Medtronic (MDT) EVP Kweli Thompson Receives Awards, Sells 1,739 Shares

What Happened
Kweli Thompson, Executive Vice President & President, Neuroscience at Medtronic (MDT), had 1,739 shares withheld on 2026-07-31 to cover taxes upon RSU vesting (proceeds ≈ $148,493). On 2026-08-03 Thompson received a package of awards: 6,923 time-based restricted stock units (RSUs), 17,306 performance share units (PSUs) (target), and 49,167 stock options (all reported as acquisitions at $0.00).

Key Details

• Filing: Form 4 filed 2026-08-04 (Period of Report: 2026-07-31). Transactions reported on 2026-07-31 and 2026-08-03.
• Sale / withholding: 1,739 shares withheld to pay taxes at $85.39 each; gross value reported ≈ $148,493 (code F: tax withholding).
• Awards (all reported as acquisitions at $0.00):
  • 6,923 RSUs — time-based; per footnote vest 100% on the third anniversary of grant.
  • 17,306 PSUs — contingent performance awards; each PSU can convert to one share if performance meets target (see PSU payout range below).
  • 49,167 stock options — derivative award; exercisability begins at 25% per year starting on the first anniversary.
• PSU payout details (footnote): if target metrics are met, 17,306 shares issued; if maximum metrics are met, up to 41,534 shares; if minimum not met, PSUs can vest at 0. Performance measurement date noted as April 27, 2029.
• Dividend reinvestment: filing notes 188 shares were acquired via dividend reinvestment since the prior report.
• Shares owned after the transactions: not specified in the provided filing excerpt.

Context

• The 1,739-share disposition was a routine tax-withholding action upon RSU vesting and is common in executive compensation—this is not an open-market sale.
• The awards are compensation-related (time-based RSUs, performance-based PSUs, and options). PSUs are contingent on future performance; options vest over multiple years. These types of grants are standard long-term incentive pay and do not by themselves signal a buy/sell opinion by the insider.